Stock DNA
Pharmaceuticals & Biotechnology
SAR 480 Million ()
NA (Loss Making)
NA
0.00%
1.32
-0.37%
1.50
Revenue and Profits:
Net Sales:
233 Million
(Quarterly Results - Mar 2008)
Net Profit:
24 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-35.44%
0%
-35.44%
6 Months
-44.05%
0%
-44.05%
1 Year
-38.96%
0%
-38.96%
2 Years
-46.53%
0%
-46.53%
3 Years
-63.17%
0%
-63.17%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Arabian International Healthcare Holding Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.20%
EBIT Growth (5y)
-13.91%
EBIT to Interest (avg)
2.26
Debt to EBITDA (avg)
5.46
Net Debt to Equity (avg)
1.53
Sales to Capital Employed (avg)
1.03
Tax Ratio
17.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.94%
ROE (avg)
11.64%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.12
EV to EBIT
37.78
EV to EBITDA
23.50
EV to Capital Employed
1.48
EV to Sales
1.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.93%
ROE (Latest)
-0.37%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Bearish
Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'08 - YoY
Mar'08
Mar'07
Change(%)
Net Sales
233.20
212.70
9.64%
Operating Profit (PBDIT) excl Other Income
44.70
53.20
-15.98%
Interest
0.90
0.40
125.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23.90
38.00
-37.11%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2008 is 9.64% vs 5.87% in Mar 2007
Consolidated Net Profit
YoY Growth in quarter ended Mar 2008 is -37.11% vs -3.31% in Mar 2007
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
806.90
642.70
25.55%
Operating Profit (PBDIT) excl Other Income
62.00
45.10
37.47%
Interest
39.90
19.90
100.50%
Exceptional Items
28.10
0.00
Consolidate Net Profit
42.30
31.40
34.71%
Operating Profit Margin (Excl OI)
57.90%
70.20%
-1.23%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 25.55% vs 3.91% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 34.71% vs -61.85% in Dec 2022
About Arabian International Healthcare Holding Co. 
Arabian International Healthcare Holding Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






